doorgaan naar inhoud
Systemic Treatment of Prostate Cancer Voorbeeldweergave van dit item
SluitenVoorbeeldweergave van dit item
Bezig met controle...

Systemic Treatment of Prostate Cancer

Auteur: Alan Horwich
Uitgever: Oxford : OUP Oxford, 2010.
Serie: Oxford oncology library.
Editie/Formaat:   eBoek : Document : EngelsAlle edities en materiaalsoorten bekijken.
Database:WorldCat
Samenvatting:
Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is  Meer lezen...
Beoordeling:

(nog niet beoordeeld) 0 met beoordelingen - U bent de eerste

Onderwerpen
Meer in deze trant

 

Zoeken naar een online exemplaar

Links naar dit item

Zoeken naar een in de bibliotheek beschikbaar exemplaar

&AllPage.SpinnerRetrieving; Bibliotheken met dit item worden gezocht…

Details

Genre/Vorm: Electronic books
Aanvullende fysieke materiaalsoort: Print version:
Horwich, Alan.
Systemic Treatment of Prostate Cancer.
Oxford : OUP Oxford, ©2010
Genre: Document, Internetbron
Soort document: Internetbron, Computerbestand
Alle auteurs / medewerkers: Alan Horwich
ISBN: 9780191575815 019157581X 1283348330 9781283348331
OCLC-nummer: 763157034
Beschrijving: 1 online resource (102 pages).
Inhoud: Biological principles of hormone therapy --
PSA as a marker of progression and response in advanced prostate cancer --
Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer --
Systemic treatment of recurrence after local therapies --
First-line hormone therapy for metastatic prostate cancer --
Second- and third-line hormone therapies --
Chemotherapy for metastatic prostate cancer --
Role of bisphosphonates in the systemic treatment of prostate cancer --
Systemic isotope therapy of bone metastasis --
Biological targets and new drug development for prostate cancer.
Serietitel: Oxford oncology library.

Fragment:

Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r.

Beoordelingen

Beoordelingen door gebruikers
Beoordelingen van GoodReads worden opgehaald...
Bezig met opvragen DOGObooks-reviews...

Tags

U bent de eerste.

Vergelijkbare items

Verwante onderwerpen:(5)

Gebruiker-lijsten met dit item (2)

Bevestig deze aanvraag

Misschien heeft u dit item reeds aangevraagd. Selecteer a.u.b. Ok als u toch wilt doorgaan met deze aanvraag.

Gekoppelde data


<http://www.worldcat.org/oclc/763157034>
library:oclcnum"763157034"
library:placeOfPublication
library:placeOfPublication
rdf:typeschema:Book
rdf:typeschema:MediaObject
rdf:valueUnknown value: dct
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:about
schema:bookFormatschema:EBook
schema:creator
schema:datePublished"2010"
schema:description"Prostate cancer is one of the commonest cancers in men in the western world, and the prevalence is rising currently due to improvements in screening and treatment. Serum PSA represents a useful marker of disease. It has frequently a long natural history, creating the opportunities for multiple sequential therapeutic interventions. For patients with high risk local disease or with metastases, endocrine therapy is central to management. Hormone ablation has long been the mainstay ofendocrine therapy in this group of patients, though anti-androgens, oestrogens and corticosteroids can also cause r."@en
schema:description"Biological principles of hormone therapy -- PSA as a marker of progression and response in advanced prostate cancer -- Neo-adjuvant and adjuvant hormone therapy for high-risk localized prostate cancer -- Systemic treatment of recurrence after local therapies -- First-line hormone therapy for metastatic prostate cancer -- Second- and third-line hormone therapies -- Chemotherapy for metastatic prostate cancer -- Role of bisphosphonates in the systemic treatment of prostate cancer -- Systemic isotope therapy of bone metastasis -- Biological targets and new drug development for prostate cancer."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/412274331>
schema:genre"Electronic books"@en
schema:inLanguage"en"
schema:isPartOf
schema:name"Systemic Treatment of Prostate Cancer"@en
schema:publication
schema:publisher
schema:url<http://public.eblib.com/choice/publicfullrecord.aspx?p=797725>
schema:url<http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=405998>
schema:url<http://www.myilibrary.com?id=334833>
schema:workExample
schema:workExample
wdrs:describedby

Content-negotiable representations

Venster sluiten

Meld u aan bij WorldCat 

Heeft u geen account? U kunt eenvoudig een nieuwe gratis account aanmaken.